Literature DB >> 26799614

An overlapping phenotype of Osteogenesis imperfecta and Ehlers-Danlos syndrome due to a heterozygous mutation in COL1A1 and biallelic missense variants in TNXB identified by whole exome sequencing.

Luisa Mackenroth1,2, Björn Fischer-Zirnsak1,3, Johannes Egerer1, Jochen Hecht1, Tilmann Kallinich4, Werner Stenzel5, Birgit Spors6, Arpad von Moers7, Stefan Mundlos1,3, Uwe Kornak1,3, Kerstin Gerhold4, Denise Horn1.   

Abstract

Osteogenesis imperfecta (OI) and Ehlers-Danlos syndrome (EDS) are variable genetic disorders that overlap in different ways [Cole 1993; Grahame 1999]. Here, we describe a boy presenting with severe muscular hypotonia, multiple fractures, and joint hyperflexibility, features that are compatible with mild OI and hypermobility type EDS, respectively. By whole exome sequencing, we identified both a COL1A1 mutation (c.4006-1G > A) inherited from the patient's mildly affected mother and biallelic missense variants in TNXB (p.Val1213Ile, p.Gly2592Ser). Analysis of cDNA showed that the COL1A1 splice site mutation led to intron retention causing a frameshift (p.Phe1336Valfs*72). Type 1 collagen secretion by the patient's skin fibroblasts was reduced. Immunostaining of a muscle biopsy obtained from the patient revealed a clear reduction of tenascin-X in the extracellular matrix compared to a healthy control. These findings imply that the combination of the COL1A1 mutation with the TNXB variants might cause the patient's unique phenotype.
© 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  COL1A1; Ehlers-Danlos syndrome; TNXB; osteogenesis imperfecta; whole exome sequencing

Mesh:

Substances:

Year:  2016        PMID: 26799614     DOI: 10.1002/ajmg.a.37547

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  6 in total

Review 1.  Bone Disease in Patients with Ehlers-Danlos Syndromes.

Authors:  Shuaa Basalom; Frank Rauch
Journal:  Curr Osteoporos Rep       Date:  2020-04       Impact factor: 5.096

Review 2.  NGS Technologies as a Turning Point in Rare Disease Research , Diagnosis and Treatment.

Authors:  Ana Fernandez-Marmiesse; Sofia Gouveia; Maria L Couce
Journal:  Curr Med Chem       Date:  2018-01-30       Impact factor: 4.530

3.  COL1A2 p.Gly1066Val variant identified in a Han Chinese family with osteogenesis imperfecta type I.

Authors:  Mingyuan Wang; Yi Guo; Pengfei Rong; Hongbo Xu; Lina Gong; Hao Deng; Lamei Yuan
Journal:  Mol Genet Genomic Med       Date:  2019-03-04       Impact factor: 2.183

4.  Compound phenotype of osteogenesis imperfecta and Ehlers-Danlos syndrome caused by combined mutations in COL1A1 and COL5A1.

Authors:  Zejia Lin; Jican Zeng; Xinjia Wang
Journal:  Biosci Rep       Date:  2019-07-25       Impact factor: 3.840

5.  Clinical and Molecular Characterization of Classical-Like Ehlers-Danlos Syndrome Due to a Novel TNXB Variant.

Authors:  Daisy Rymen; Marco Ritelli; Nicoletta Zoppi; Valeria Cinquina; Cecilia Giunta; Marianne Rohrbach; Marina Colombi
Journal:  Genes (Basel)       Date:  2019-10-25       Impact factor: 4.096

6.  A novel splicing pathogenic variant in COL1A1 causing osteogenesis imperfecta (OI) type I in a Chinese family.

Authors:  Yaxin Han; Dongming Wang; Jinli Guo; Qiuhong Xiong; Ping Li; Yong-An Zhou; Bin Zhao
Journal:  Mol Genet Genomic Med       Date:  2020-06-25       Impact factor: 2.183

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.